Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Indivumed GmbH. (12/12/21). "Press Release: Indivumed Appoints Dr. Stephan Schüller as CFO".

Organisations Organisation Indivumed GmbH
  Group Indivumed (Group)
  Organisation 2 Bankhaus Lampe KG
  Group Oetker (Group)
Products Product personalised medicine / precision medicine
  Product 2 banking
Persons Person Schüller, Stephan (Indivumed 202112– CFO before Bankhaus Lampe KG + Vereins- und Westbank AG)
  Person 2 Juhl, Hartmut (Indivumed 200701 CEO + founder)
     


Indivumed is pleased to announce that Dr. Stephan Schüller has joined Indivumed as Chief Financial Officer. With more than 30 years of experience as a business executive, professor, and board member, Dr. Schüller brings highly valuable knowledge and perspectives to Indivumed.

“It is a pleasure to support Indivumed in the current growth phase,” said Dr. Schüller. “Indivumed has a unique opportunity to realize better cancer care by data- and AI-driven precision oncology and it is a great privilege for me that I am allowed to contribute from a financial perspective realizing the full value of this amazing company.”

A prominent financial leader, Dr. Schüller studied business economics at the Westfälische Wilhelms-Universität in Münster, Germany. Since 1992, Schüller has taught business politics of financial institutions at the University of Duisburg-Essen and the Mercator School of Management.

Prior to joining Indivumed, Dr. Schüller was the CEO of Bankhaus Lampe KG in Düsseldorf and Vereins-und Westbank AG in Hamburg, respectively. Dr. Schüller was also a board member for several financial institutions, including Vereins-und Westbank AG in Hamburg and HypoVereinsbank AG (formerly Bayrische Vereinsbank) in München.

“I am honored that Stephan Schüller has decided to join Indivumed. With him we could win a worldwide highly respected financial expert to support Indivumed in becoming the leading AI- and data-driven company for precision oncology.” said Dr. Hartmut Juhl, Founder and CEO of Indivumed.

   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x200px

More documents for Indivumed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top